About us

NTT BIOPHARMA

Nano Targeting and Therapy (NTT) Biopharma Inc. is a cutting-edge biotechnology company pioneering the use of mesoporous silica nanoparticles (MSNs) for the precise and efficient delivery of therapeutic molecules. Our vision is to tackle critical challenges and deliver improved solutions in drug delivery to address unmet medical needs in the fields of brain diseases, ocular and retinal diseases, oncology, and gene therapy. We are committed to create a new generation of effective nanomedicines that optimize therapies across a broad range of diseases.

Technology

MESOPOROUS SILICA NANOPARTICLE AS A DRUG-DELIVERY PLATFORM FOR OVERCOMING THE HURDLES OF DRUG DELIVERY

NTT’s proprietary mesoporous silica nanoparticles (MSNs) provide a highly tunable drug delivery platform with superior loading capacity, targeted delivery, and improved therapeutic efficacy with reduced side effects. This platform is designed to address key challenges in drug delivery and unlock new treatment possibilities.
NTT is advancing its MSN technology across a range of high-impact medical applications to offer a promising approach for unmet medical needs.